QyScore, Imaging Software that Analyzes MRI Markers of Brain Disease, Earns FDA Clearance
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QyScore, a cloud-based imaging software for the automated…
Articles by Alberto Molano, PhD
Miscarriage or Ectopic Pregnancy Not More Likely in Women Using Rebif, Study Suggests
Results from a large observational study of pregnant women with multiple sclerosis (MS) treated with an interferon (IFN) beta-1a,…
Relative Cancer Risk is Higher in MS Patients Who Switch Disease-modifying Treatments More Frequently, Study Finds
The relative risk of developing cancer was found to be higher in multiple sclerosis (MS) patients who more frequently…
Early Safety Data from Phase 1 Study of Immunotherapy in Progressive MS Patients To Be Detailed at EAN
Early, positive safety results from a Phase 1 trial testing a potential immunotherapy, ATA188, in people with progressive multiple sclerosis will…
Machine System Based on Brain Activity May Restore Speech to Those Who Lost It, Study Reports
A study suggests that it may be possible to create synthetic speech based on recordings of brain activity in people…
In-Depth Study into MS Progression Gets $2M Boost from Roche Canada
Roche Canada is contributing $2.125 million to the Canadian Prospective Cohort Study to Understand Progression in MS (CanProCo),…
$1.5M Earmarked for MS Research on Cannabis in Canada
In partnership with the Canadian Institutes of Health Research, the MS Society of Canada has announced $1.5 million to fund research…
Immunic Therapeutics Enrolls First Patient in Phase 2 Trial of IMU-838 for RRMS
Immunic Therapeutics has enrolled the first patient in its Phase 2 clinical trial testing IMU-838, a potential oral therapy for …
Study Indicates Possible Correlation Between Nutritional Status, MS
Multiple sclerosis (MS) patients eat a more limited diet, with a lower average of 31 nutrients, including zinc, thiamin, and…
Controlling Spasticity Would Greatly Improve Everyday Quality of Life, Survey Shows
An international survey of caregivers and adults with neurological diseases, including multiple sclerosis (MS), revealed that spasticity is a…
Bafiertam, a Bioequivalent of Tecfidera, Receives Tentative OK from FDA for RRMS
Banner Life Sciences has received tentative approval from the U.S. Food and Drug Administration (FDA) for its new drug application (NDA)…
Study Links Food Allergies and Increased MS Disease Activity
Multiple sclerosis (MS) patients who reported food allergies showed a 27 percent higher cumulative rate of flare-ups over the…
FDA Gives Green Light to Phase 2 Trial of NurOwn Stem Cell Therapy in Progressive MS Patients
The U.S. Food and Drug Administration (FDA) has approved BrainStorm Cell Therapeutics‘ request to open a Phase 2 clinical trial…
Tysabri Seen as Superior to IFN-β in Preventing Relapses, Easing Disability in Small Study
Tysabri (natalizumab) was found to be superior to interferon beta (IFN-β) in a small, 12-month study with…
CDC Launching National Neurological Conditions Surveillance System to Study MS
The U.S. Congress is supporting with $5 million the National Neurological Conditions Surveillance System (NNCSS), an initiative to be…
Heavy Caseloads for MS Specialist Nurses in UK Compromise Patient Care, MS Trust Reports
Nurses who specialize in treating multiple sclerosis (MS) patients in the U.K. are handling heavier caseloads than recommended or preferred,…
Study Highlights Need for Better Engagement Between MS Patients and Healthcare Providers
Multiple sclerosis (MS) relapses can be challenging for some patients, and better engagement is needed between patients and their healthcare…